Daniel Kahn
Nurse Practitioner - Primary Care β’ Boston, MA
1340 Boylston St
Boston, MA 022154302
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Daniel Kahn is listed in NPPES under Nurse Practitioner - Primary Care.
-
NPI assigned on April 19, 2016; this date does not establish years in practice.
-
Published CMS data list 246 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium β 30 prescription fills, including refills.
- Lisinopril β 25 prescription fills, including refills.
- Biktarvy (Bictegrav/Emtricit/Tenofov Ala) β 23 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 15 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 60% of clinicians listed under Nurse Practitioner - Primary Care in Boston, MA (2024, 20 clinicians with data). Median for this group: 377. Middle half: 147 to 1,064.
Fewer Part D prescriptions than 65% of clinicians listed under Nurse Practitioner - Primary Care in Massachusetts (2024, 180 clinicians with data). Median for this group: 586. Middle half: 181 to 1,728.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 129 in 2020 to 246 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2020β2024.
Practice Location & Contact Primary Location
1340 Boylston St
Boston, MA 022154302
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Fenway Community Health Center, Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2016
What Public CMS Data Show
Nurse Practitioner - Primary Care: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
398 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$238,248 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2023
All general payments: $330.17 across 17 records.
By nature of payment
- Food and Beverage: $330.17 across 17 records.
Reporting-company totals (3 largest of 9)
- Novo Nordisk Inc: $82.73 across 5 records.
- IDORSIA PHARMACEUTICALS US INC: $63.78 across 3 records.
- Salix Pharmaceuticals, a division of Bausch Health US, LLC: $34.45 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2023 (published June 30, 2026).
Years since graduation
10 years (graduated 2016)
CMS Doctors and Clinicians data list 2016 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2016
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Daniel Kahn has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Daniel Kahn as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Boston and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 60% of clinicians listed under Nurse Practitioner - Primary Care in Boston, MA (2024, 20 clinicians with data). Median for this group: 377. Middle half: 147 to 1,064.
Fewer Part D prescriptions than 65% of clinicians listed under Nurse Practitioner - Primary Care in Massachusetts (2024, 180 clinicians with data). Median for this group: 586. Middle half: 181 to 1,728.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Nurse Practitioner - Primary Care in Boston, MA (2024, 20 clinicians with data). Median for this group: $58,671. Middle half: $3,492 to $176,062.
A higher Part D drug cost than 80% of clinicians listed under Nurse Practitioner - Primary Care in Massachusetts (2024, 180 clinicians with data). Median for this group: $43,198. Middle half: $2,819 to $154,994.
62 active clinicians are listed under Nurse Practitioner - Primary Care with a practice address in Boston, MA (376 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Boston
19.4% of these 62 clinicians have the CMS telehealth indicator.
40.3% of these 62 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 91% from 129 in 2020 to 246 in 2024.
- 2020: 129
- 2021: 241
- 2022: 276
- 2023: 263
- 2024: 246
-
30-day fills
30-day fills increased 142% from 164 in 2020 to 398 in 2024.
- 2020: 164
- 2021: 312
- 2022: 350
- 2023: 352
- 2024: 398
-
Part D drug cost
Part D drug cost increased 124% from $106,249 in 2020 to $238,248 in 2024.
- 2020: $106,249
- 2021: $123,481
- 2022: $311,569
- 2023: $318,748
- 2024: $238,248
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2023 only.
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2023), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2023 (payments made January 1 β December 31, 2023): 17 records totaling $330.17.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $33.46 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $28.69 |
| IDORSIA PHARMACEUTICALS US INC |
Food and Beverage
In-kind items and services
|
QUVIVIQ | General | $21.27 |
| IDORSIA PHARMACEUTICALS US INC |
Food and Beverage
In-kind items and services
|
QUVIVIQ | General | $21.26 |
| IDORSIA PHARMACEUTICALS US INC |
Food and Beverage
In-kind items and services
|
QUVIVIQ | General | $21.25 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
SHINGRIX | General | $21.00 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
XARELTO | General | $20.57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $18.89 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
β | General | $17.43 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $17.05 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $16.51 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $16.43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $15.56 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
GARDASIL 9 | General | $15.55 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
β | General | $15.31 |
| TOLMAR, INC. |
Food and Beverage
In-kind items and services
|
JATENZO | General | $15.11 |
| TOLMAR, INC. |
Food and Beverage
In-kind items and services
|
JATENZO | General | $14.83 |
Source: CMS Open Payments, program year 2023, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 30 | 1,602 | $425.78 | β |
| Lisinopril | Lisinopril | 25 | 1,549 | $238.75 | β |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 23 | 672 | $89,061.98 | β |
| Atorvastatin Calcium | Atorvastatin Calcium | 21 | 1,800 | $166.95 | β |
| Triumeq | Abacavir/Dolutegravir/Lamivudi | 18 | 540 | $60,565.88 | β |
| Bupropion Xl | Bupropion Hcl | 16 | 720 | $232.34 | β |
| Valacyclovir | Valacyclovir Hcl | 16 | 355 | $443.79 | β |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | 175 | $186.95 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 14 | 303 | $501.35 | β |
| Emtricitabine-Tenofovir Disop | Emtricitabine/Tenofovir (Tdf) | 13 | 930 | $34,106.81 | β |
| Gabapentin | Gabapentin | 11 | 330 | $55.82 | β |
| Omeprazole | Omeprazole | 11 | 810 | $182.52 | β |
| Tamsulosin Hcl | Tamsulosin Hcl | 11 | 870 | $148.76 | β |
| Testosterone Cypionate | Testosterone Cypionate | 11 | 119 | $206.97 | β |
| Symtuza | Darunavir/Cob/Emtri/Tenof Alaf | 11 | 330 | $51,723.37 | β |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-09-17NUCC Taxonomy Code: 363LP2300X
NUCC Taxonomy Code: 163WC1500X
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20240226003214
MA
1759666308
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Fenway Community Health Center, Inc
1340 Boylston St, Boston, MA 022154302
Phone: 6172670900
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Medicine (M.D.)
Obstetrics & Gynecology
Doctor of Medicine (M.D.)
Nurse Practitioner
Nurse Practitioner
Physician Assistant
Physician Assistant
Internal Medicine
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Nurse Practitioner
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1340 BOYLSTON ST, BOSTON, MA 022154302 (Tel: 6172477555)
Registered at 1340 BOYLSTON ST, BOSTON, MA 022154302 (Tel: 6172477555)
Nurse Practitioner (license number reported to NPPES: MA RN2299146)
NPI status registered as active in NPPES database
Registered at 142 BERKELEY STREET, BOSTON, MA 02216 (Tel: 6172477555)
Registered at 142 BERKELEY STREET, BOSTON, MA 02216 (Tel: 6172477555)
Recorded as DANIEL KAHN
Registered Nurse (license number reported to NPPES: MA RN2299146)
Registered at 142 BERKELEY ST, BOSTON, MA 021165100 (Tel: 5512069852)
Registered at 142 BERKELEY STREET, BOSTON, MA 02216 (Tel: 5512069852)
NPI status registered as active in NPPES database
Registered at 1340 BOYLSTON ST, BOSTON, MA 022154302 (Tel: 5512069852)
Registered at 1340 BOYLSTON ST, BOSTON, MA 022154302 (Tel: 5512069852)
Recorded as DANIEL KAHN
Registered Nurse (license number reported to NPPES: MA RN2299146)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioner - Primary Care Specialists in Boston
- Liliana Fera, NP-C
- Michaela Gee, RN
- Adam Corl, NP
- Cathleen Power, NP
- Linda Debeasi, RN, NP
- Jacqueline Roman
Mailing Address
1340 Boylston St
Boston, MA 022154302
Phone: 6172477555